235 related articles for article (PubMed ID: 11829528)
1. Generation of helper-dependent adenoviral vectors by homologous recombination.
Toietta G; Pastore L; Cerullo V; Finegold M; Beaudet AL; Lee B
Mol Ther; 2002 Feb; 5(2):204-10. PubMed ID: 11829528
[TBL] [Abstract][Full Text] [Related]
2. Improved vascular gene transfer with a helper-dependent adenoviral vector.
Wen S; Graf S; Massey PG; Dichek DA
Circulation; 2004 Sep; 110(11):1484-91. PubMed ID: 15326058
[TBL] [Abstract][Full Text] [Related]
3. The host response to adenovirus, helper-dependent adenovirus, and adeno-associated virus in mouse liver.
McCaffrey AP; Fawcett P; Nakai H; McCaffrey RL; Ehrhardt A; Pham TT; Pandey K; Xu H; Feuss S; Storm TA; Kay MA
Mol Ther; 2008 May; 16(5):931-41. PubMed ID: 18388926
[TBL] [Abstract][Full Text] [Related]
4. A convenient plasmid system for construction of helper-dependent adenoviral vectors and its application for analysis of the breast-cancer-specific mammaglobin promoter.
Shi CX; Graham FL; Hitt MM
J Gene Med; 2006 Apr; 8(4):442-51. PubMed ID: 16389604
[TBL] [Abstract][Full Text] [Related]
5. Helper-dependent adenovirus for the gene therapy of proliferative retinopathies: stable gene transfer, regulated gene expression and therapeutic efficacy.
Lamartina S; Cimino M; Roscilli G; Dammassa E; Lazzaro D; Rota R; Ciliberto G; Toniatti C
J Gene Med; 2007 Oct; 9(10):862-74. PubMed ID: 17685494
[TBL] [Abstract][Full Text] [Related]
6. Development of a FLP/frt system for generating helper-dependent adenoviral vectors.
Ng P; Beauchamp C; Evelegh C; Parks R; Graham FL
Mol Ther; 2001 May; 3(5 Pt 1):809-15. PubMed ID: 11356086
[TBL] [Abstract][Full Text] [Related]
7. Targeting of high-capacity adenoviral vectors.
Biermann V; Volpers C; Hussmann S; Stock A; Kewes H; Schiedner G; Herrmann A; Kochanek S
Hum Gene Ther; 2001 Sep; 12(14):1757-69. PubMed ID: 11560769
[TBL] [Abstract][Full Text] [Related]
8. Persistent hepatic expression of human apo A-I after transfer with a helper-virus independent adenoviral vector.
Van Linthout S; Lusky M; Collen D; De Geest B
Gene Ther; 2002 Nov; 9(22):1520-8. PubMed ID: 12407424
[TBL] [Abstract][Full Text] [Related]
9. Transient foamy virus vector production by adenovirus vectors.
Russell RA; Vassaux G; Martin-Duque P; McClure MO
Gene Ther; 2004 Feb; 11(3):310-6. PubMed ID: 14737091
[TBL] [Abstract][Full Text] [Related]
10. Constructing adenoviral vectors by using the circular form of the adenoviral genome cloned in a cosmid and the Cre-loxP recombination system.
Tashiro F; Niwa H; Miyazaki J
Hum Gene Ther; 1999 Jul; 10(11):1845-52. PubMed ID: 10446924
[TBL] [Abstract][Full Text] [Related]
11. Helper-dependent adenoviral vector-mediated delivery of woodchuck-specific genes for alpha interferon (IFN-alpha) and IFN-gamma: IFN-alpha but not IFN-gamma reduces woodchuck hepatitis virus replication in chronic infection in vivo.
Fiedler M; Rödicker F; Salucci V; Lu M; Aurisicchio L; Dahmen U; Jun L; Dirsch O; Pützer BM; Palombo F; Roggendorf M
J Virol; 2004 Sep; 78(18):10111-21. PubMed ID: 15331744
[TBL] [Abstract][Full Text] [Related]
12. Long-term stable correction of low-density lipoprotein receptor-deficient mice with a helper-dependent adenoviral vector expressing the very low-density lipoprotein receptor.
Oka K; Pastore L; Kim IH; Merched A; Nomura S; Lee HJ; Merched-Sauvage M; Arden-Riley C; Lee B; Finegold M; Beaudet A; Chan L
Circulation; 2001 Mar; 103(9):1274-81. PubMed ID: 11238273
[TBL] [Abstract][Full Text] [Related]
13. Optimization of the helper-dependent adenovirus system for production and potency in vivo.
Sandig V; Youil R; Bett AJ; Franlin LL; Oshima M; Maione D; Wang F; Metzker ML; Savino R; Caskey CT
Proc Natl Acad Sci U S A; 2000 Feb; 97(3):1002-7. PubMed ID: 10655474
[TBL] [Abstract][Full Text] [Related]
14. Adeno-cosmid cloning vectors for regulated gene expression.
Giampaoli S; Nicolaus G; Delmastro P; Cortese R
J Gene Med; 2002; 4(5):490-7. PubMed ID: 12221642
[TBL] [Abstract][Full Text] [Related]
15. Production of helper-dependent adenovirus vector relies on helper virus structure and complementing.
Zhou HS; Zhao T; Rao XM; Beaudet AL
J Gene Med; 2002; 4(5):498-509. PubMed ID: 12221643
[TBL] [Abstract][Full Text] [Related]
16. Replication and packaging of helper-dependent adenoviral vectors.
Sato M; Suzuki S; Kubo S; Mitani K
Gene Ther; 2002 Apr; 9(7):472-6. PubMed ID: 11938462
[TBL] [Abstract][Full Text] [Related]
17. Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration.
Parks R; Evelegh C; Graham F
Gene Ther; 1999 Sep; 6(9):1565-73. PubMed ID: 10490766
[TBL] [Abstract][Full Text] [Related]
18. Gutted adenoviral vector growth using E1/E2b/E3-deleted helper viruses.
Barjot C; Hartigan-O'Connor D; Salvatori G; Scott JM; Chamberlain JS
J Gene Med; 2002; 4(5):480-9. PubMed ID: 12221641
[TBL] [Abstract][Full Text] [Related]
19. PEGylated helper-dependent adenoviral vectors: highly efficient vectors with an enhanced safety profile.
Croyle MA; Le HT; Linse KD; Cerullo V; Toietta G; Beaudet A; Pastore L
Gene Ther; 2005 Apr; 12(7):579-87. PubMed ID: 15647765
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic T lymphocyte responses to proteins encoded by heterologous transgenes transferred in vivo by adenoviral vectors.
Song W; Kong HL; Traktman P; Crystal RG
Hum Gene Ther; 1997 Jul; 8(10):1207-17. PubMed ID: 9215738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
